eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Manuscripts accepted About the journal Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
2/2019
vol. 15
 
Share:
Share:
more
 
 
abstract:
Clinical research

Vitamin D level is associated with severity of coronary artery atherosclerosis and incidence of acute coronary syndromes in non-diabetic cardiac patients

Ewelina A. Dziedzic, Jakub S. Gąsior, Mariusz Pawłowski, Beata Wodejko-Kucharska, Tomasz Saniewski, Anna Marcisz, Marek J. Dąbrowski

Arch Med Sci 2019; 15, 2: 359–368
Online publish date: 2019/03/04
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
Ischaemic heart disease is the main cause of death in developed countries. There are many modifiable risk factors associated with coronary heart disease (CAD). A growing number of studies point to vitamin D deficiency as a risk factor for heart attacks and the conditions associated with cardiovascular disease. This study aimed to analyse the relationship between the level of 25-hydroxyvitamin D (25(OH)D) and the severity of coronary artery atherosclerosis and to study 25(OH)D levels in non-diabetic patients hospitalised due to acute coronary syndrome and those diagnosed with stable CAD.

Material and methods
Coronary angiography was performed prospectively in 410 successive cardiac patients. The severity of coronary artery atherosclerosis was assessed according to the Coronary Artery Surgery Study Score (CASSS). The plasma 25(OH)D level was assessed with the electrochemiluminescence method.

Results
The 25(OH)D level proved to be one of the significant determinants of the CASSS (p < 0.05). In subjects without significant lesions in the coronary arteries the 25(OH)D level was significantly higher compared to patients with one- to three-vessel coronary atherosclerosis (p < 0.05). A significantly higher 25(OH)D level was noted in patients diagnosed with stable CAD compared to patients hospitalised due to acute coronary syndrome (p < 0.01).

Conclusions
Patients with one- to three-vessel atherosclerosis have a significantly lower 25(OH)D level compared to patients without significant lesions in the coronary arteries. A lower 25(OH)D level was observed in patients hospitalised due to acute coronary syndrome compared to patients diagnosed with stable CAD.

keywords:

vitamin D, coronary atherosclerosis, cardiometabolic risk factors

references:
Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005; 94: 483-92.
Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-30.
Giovannucci E. Expanding roles of vitamin D. J Clin Endocrinol 2009; 94: 418-20.
Swanson CM, Nielson CM, Shrestha S, et al. Higher 25(OH)D2 is associated with lower 25(OH)D3 and 1,25(OH)2D3. J Clin Endocrinol Metab 2014; 99: 2736-44.
Nair R, Maseeh A. Vitamin D: the “sunshine” vitamin. J Pharmacol Pharmacother 2012; 3: 118-26.
Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 2014; 21: 319-29.
Dziedzic E, Dabrowski MJ. Is vitamin D a new therapeutic option in coronary artery disease? Overview data. Cardiol Pharmacol 2015; S1: 003.
Krela-Kaźmierczak I, Szymczak A, Łykowska-Szuber L, et al. The importance of vitamin D in the pathology of bone metabolism in inflammatory bowel diseases. Arch Med Sci 2015; 11: 1028-32.
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the emode-angiotensin system. J Clin Invest 2002; 110: 229-38.
Brewer LC, Michos ED, Reis JP. Vitamin D in atherosclerosis, vascular disease, and endothelial function. Curr Drug Targets 2011; 12: 54-60.
Pilz S, Tomaschitz A, Drechsler C, Dekker JM, März W. Vitamin D deficiency and myocardial diseases. Mol Nutr Food Res 2010; 54: 1103-13.
Chen S, Glenn DJ, Ni W, et al. Expression of the vitamin D receptor is increased in the hypertrophic heart. Hypertension 2008; 52: 1106-12.
Somjen D, Weisman Y, Kohen F, et al. 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 2005; 111: 1666-71.
Xiang W, Kong J, Chen S, et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac emode-angiotensin systems. Am J Physiol Endocrinol Metab 2005; 288: 125-32.
Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D. Calcium-independent and 1,25(OH2)D3-dependent regulation of the emode-angiotensin system in 1a-hydroxylase knockout mice. Kidney Int 2008; 74: 170-9.
Kassi E, Adamopoulos C, Basdra EK, Papavassiliou AG. Role of vitamin D in atherosclerosis. Circulation 2013; 128: 2517-31.
Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007; 167: 1159-65.
Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc 2011; 86: 50-60.
Ferrario CM, Strawn WB. Role of the renin angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 2006; 98: 121-8.
Gagnon C, Lu ZX, Magliano DJ, et al. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study. J Clin Endocrinol Metab 2012; 97: 1953-61.
Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and metaanalysis. J Clin Endocrinol Metab 2007; 92: 2017-29.
Lamendola CA, Ariel D, Feldman D, Reaven GM. Relations between obesity, insulin resistance, and 25-hydroxyvitamin D. Am J Clin Nutr 2012; 95: 1055-105.
Dziedzic EA, Przychodzeń S, Dąbrowski M. The effects of vitamin D on severity of coronary artery atherosclerosis and lipid profile of cardiac patients. Arch Med Sci 2016; 12: 1199-206.
Ringqvist I, Fisher LD, Mock M, et al. Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest 1983; 71: 1854-66.
Wielders JP, Carter GF, Eberl H, Morris G, Roth HJ, Vogl C. Automated competitive protein-binding assay for total 25-OH vitamin D, multicenter evaluation and practical performance. J Clin Lab Anal 2015; 29: 451-61.
Ashwell M, Stone EM, Stolte H, et al. UK Food Standards Agency Workshop Report: an investigation of the relative contributions of diet and sunlight to vitamin D status. Br J Nutr 2010; 104: 603-11.
Black LJ, Anderson D, Clarke MW, Ponsonby AL, Lucas RM; Ausimmune Investigator Group. Analytical bias in the measurement of serum 25-hydroxyvitamin D concentrations impairs assessment of vitamin D status in clinical and research settings. PLoS One 2015; 10: e0135478.
Shin SY, Kwon MJ, Song J, Park H, Woo HY. Measurement of serum total vitamin D (25-OH) using automated immunoassay in comparison [corrected] with liquid chromatography tandem-mass spectrometry. J Clin Lab Anal 2013; 27: 284-9.
Knudsen CS, Nexo E, Højskov CS, Heickendorff L. Analytical validation of the Roche 25-OH vitamin D total assay. Clin Chem Lab Med 2012; 50: 1965-8.
Abdel-Wareth L, Haq A, Turner A, et al. Total vitamin D assay comparison of the Roche Diagnostics “Vitamin D total” electrochemiluminescence protein binding assay with the Chromsystems HPLC method in a population with both D2 and D3 forms of vitamin D. Nutrients 2013; 5: 971-80.
Spiro A, Buttriss JL. Vitamin D: an overview of vitamin D status and intake in Europe. Nutr Bull 2014; 39: 322-50.
Lee JH, Gadi R, Spertus JA, Tang F, O’Keefe JH. Prevalence of vitamin D deficiency in patients with acute myocardial infarction. Am J Cardiol 2011; 107: 1636-8.
Pludowski P, Holick MF, Pilz S, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality – a review of recent evidence.
Autoimmun Rev 2013; 12: 976-89.
Hilger J, Friedel A, Herr R, et al. A systematic review of vitamin D status in populations worldwide. Br J Nutr 2014; 111: 23-45.
Pludowski P, Grant WB, Bhattoa HP, et al. Vitamin D status in Central Europe. Int J Endocrinol 2014; 2014: 589587.
Yetley EA. Assessing the vitamin D status of the US population. Am J Clin Nutr 2008; 88: 558S-64S.
Zadshir A, Tareen N, Pan D, Norris K, Martins D. The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis 2005; 15 (4 Suppl 5): S5-97-101.
Schneider AL, Lutsey PL, Selvin E et al. Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study. Eur J Neurol 2015; 22: 1220-7.
Mazidi M, Michos ED, Banach M. The association of telomere length and serum 25-hydroxyvitamin D levels in US adults: the National Health and Nutrition Examination Survey. Arch Med Sci 2017; 13: 61-5.
Michos ED, Misialek JR, Selvin E, et al. 25-hydroxyvitamin D levels, vitamin D binding protein gene polymorphisms and incident coronary heart disease among whites and blacks: the ARIC study. Atherosclerosis 2015; 241: 12-7.
Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008; 168: 1629-37.
Płudowski P, Ducki C, Konstantynowicz J, Jaworski M. Vitamin D status in Poland. Pol Arch Med Wewn 2016; 126: 530-9.
Płudowski P, Konstantynowicz J, Jaworski M, et al. Assessment of supply of vitamin D in the adult population in Poland. Standardy Med Pediatria 2014; 4: 609-17.
Kmieć P, Żmijewski M, Waszak P, Sworczak K, Lizakow­ska-Kmieć M. Vitamin D deficiency during winter months among an adult, predominantly urban, population in Northern Poland. Endokrynol Pol 2014; 65: 105-13.
Puchner SB, Liu T, Mayrhofer T, et al. High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain: results from the ROMICAT-II trial. J Am Coll Cardiol 2015; 64: 684-92.
Beręsewicz A. Pathophysiology of atherosclerosis and cardiovascular disease. Poland 2011.
Oh J, Weng S, Felton SK, et al. 1,25(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009; 120: 687-98.
Timms PM, Mannan N, Hitman GA, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders. QJM 2002; 95: 787-96.
Fic P, Zakrocka I, Kurzepa J, Stepulak A. [Matrix metalloproteinases and atherosclerosis]. Postepy Hig Med Dosw 2011; 65: 16-27.
Osborne JE, Hutchinson PE. Vitamin D and systemic cancer: is this relevant to malignant melanoma? Br J Dermatol 2002; 147: 197-213.
Ohsawa M, Koyama T, Yamamoto K, Hirosawa S, Kamei S, Kamiyama R. 1alpha, 25-dihydroxyvitamin D(3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation 2000; 102: 2867-72.
Stach K, Kalsch AI, Nguyen XD, et al. 1alpha, 25-dihydroxyvitamin D3 attenuates platelet activation and the expression of vcam-1 and mt1-mmp in human endothelial cells. Cardiology 2011; 118: 107-15.
Shor R, Tirosh A, Shemesh L, et al. 25 hydroxyvitamin D levels in patients undergoing coronary artery catheterization. Eur J Intern Med 2012; 23: 470-3.
Syal SK, Kapoor A, Bhatia E, et al. Vitamin D deficiency, coronary artery disease, and endothelial dysfunction: observations from a coronary angiographic study in Indian patients. J Invasive Cardiol 2012; 24: 385-9.
Verdoia M, Schaffer A, Sartori C, et al. Vitamin D deficiency is independently associated with the extent of coronary artery disease. Eur J Clin Invest 2014; 44: 634-42.
Taylor KS, Heneghan CJ, Farmer AJ, et al. All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database. Diabetes Care 2013; 36: 2366-71.
Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117: 503-11.
Khalili H, Talasaz AH, Salarifar M. Serum vitamin D concentration status and its correlation with early biomarkers of emodelling following acute myocardial infarction. Clin Res Cardiol 2012; 101: 321-7.
Ng LL, Sandhu JK, Squire IB, Davies JE, Jones DJ. Vitamin D and prognosis in acute myocardial infarction. Int J Cardiol 2013; 168: 2341-6.
Kilkkinen A, Knekt P, Aro A, et al. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 2009; 170: 1032-9.
Mazidi M, Rezaie P, Vatanparast H, Kengne AP. Effect of statins on serum vitamin D concentrations: a systematic review and meta-analysis. Eur J Clin Invest 2017; 47: 93-101.
Sahebkar A, Reiner Ž, Simental-Mendía LE, Ferretti G, Corte CD, Nobili V. Impact of statin therapy on plasma vitamin D levels: a systematic review and meta-analysis. Curr Pharm Des 2017; 23: 861-9.
FEATURED PRODUCTS
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe